|
Real-time Estimate
Cboe BZX
15:58:29 11/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 41.04 USD | -1.92% |
|
-15.11% | +25.22% |
| 09-10 | Exchange-Traded Funds Lower, Equity Futures Mixed Pre-Bell Thursday Amid Producer Price Inflation Data Release | MT |
| 09-10 | Axogen, Inc., BioCircuit Technologies, Inc. - M&A Call |
Company Valuation: Axogen, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 389.4 | 422 | 294 | 725.3 | 1,510 | 2,250 | - | - |
| Change | - | 8.37% | -30.34% | 146.7% | 108.14% | 49.04% | - | - |
| Enterprise Value (EV) | 389.4 | 422 | 294 | 725.3 | 1,510 | 2,250 | 2,250 | 2,250 |
| Change | - | 8.37% | -30.34% | 146.7% | 108.14% | 49.04% | 0% | 0% |
| P/E | -14.4x | -14.5x | -13.4x | -71.7x | -96.3x | -93.5x | 698x | 170x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | -2.36x | 0.5x | 1.3x | -2x | -3x | -6x | 1x |
| Capitalization / Revenue | 3.06x | 3.05x | 1.85x | 3.87x | 6.7x | 8.05x | 6.7x | 5.46x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 8.05x | 6.7x | 5.46x |
| EV / EBITDA | -0x | -0x | -0x | 0x | 0x | 67.7x | 45.8x | 32.2x |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -271x | 2,459x | 162x |
| EV / FCF | - | -0x | -0x | - | -0x | 293x | 74.3x | 48.4x |
| FCF Yield | - | -8.56% | -6.66% | - | -0.19% | 0.34% | 1.35% | 2.07% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.65 | -0.69 | -0.51 | -0.23 | -0.34 | -0.4475 | 0.06 | 0.246 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 127.4 | 138.6 | 159 | 187.3 | 225.2 | 279.6 | 335.7 | 411.9 |
| EBITDA 1 | -19.94 | -9.259 | -1.12 | 19.84 | 27.92 | 33.26 | 49.13 | 69.96 |
| EBIT 1 | -25.42 | -29.71 | -21.46 | -3.287 | -7.849 | -8.292 | 0.915 | 13.85 |
| Net income 1 | -26.98 | -28.95 | -21.72 | -9.964 | -15.7 | -24.35 | 3.044 | 14.06 |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 9.37 | 9.98 | 6.83 | 16.48 | 32.73 | 41.85 | 41.85 | 41.85 |
| Nbr of stocks (in thousands) | 41,563 | 42,287 | 43,044 | 44,008 | 46,122 | 53,762 | - | - |
| Announcement Date | 22/02/22 | 14/03/23 | 05/03/24 | 25/02/25 | 24/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -93.52x | - | - | - | 2.25B | |
| 29.98x | 5.3x | 20.33x | 0.31% | 223B | |
| 33.82x | 6.13x | 19.45x | 0.7% | 141B | |
| 39.06x | 10.28x | 22.68x | -.--% | 127B | |
| 16.26x | 3.34x | 10.87x | -.--% | 62.46B | |
| 19.09x | 2.3x | 11.55x | 2.67% | 49.73B | |
| 34.29x | 6.86x | 21.7x | -.--% | 50.01B | |
| 27.88x | 5.54x | 18.81x | 0.72% | 40.35B | |
| 70.32x | 6.73x | 20.5x | -.--% | 39.46B | |
| 18.81x | 5.24x | 13.54x | 1.21% | 31.41B | |
| Average | 19.60x | 5.75x | 17.71x | 0.62% | 76.7B | |
| Weighted average by Cap. | 31.80x | 6.11x | 18.95x | 0.48% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- AXGN Stock
- Valuation Axogen, Inc.
Select your edition
All financial news and data tailored to specific country editions
